NCT01757431View on ClinicalTrials.gov

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 16, 2012

Primary Completion Date

September 24, 2013

Study Completion Date

September 25, 2013

Conditions
Atypical Hemolytic Uremic Syndrome (aHUS)
Interventions
DRUG

Eculizumab

Trial Locations (2)

Unknown

Nagano Red Cross Hospital, Nagano

Tokyo Medical and Dental University Hospital, Tokyo

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY